Blood glucose lowering and anti-oxidant potential of erythritol: An in vitro and in vivo study
Journal of Diabetes & Metabolic Disorders · 29.05.2023 · 22 (2) · 1217-1229
DOI: 10.1007/s40200-023-01237-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes & Metabolic Disorders, online erschienen am 29.05.2023. Verfasst von O A Soetan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Reproduction and Bionformatics Research Unit, Ladoke Akintola University of Technology, Ogbomosho, Oyo Nigeria. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Diabetes is a major cause of death worldwide and Nigeria is not an exception. The quest to lower sugar levels has become a major factor in the management of diabetes; this has occasioned the use of substitutes for refined sugar in beverages. Erythritol is a natural sweetener gaining immense interest in recent times. Like metformin, erythritol has shown hydroxyl radical scavenging ability and has metabolic profile suitable for diabetics. Therefore, the blood glucose-lowering and anti-oxidant properties of erythritol under in vitro and in vivo systems were accessed.
Methods
Radical scavenging assay (ABTS and DPPH) and inhibition of carbohydrate digestive enzymes (alpha-amylase and alpha-glucosidase) were employed to determine in vitro anti-oxidant and glucose regulatory function of erythritol respectively. Molecular docking studies were performed between 3D structures of human pancreatic alpha-amylase and alpha-glucosidase, isomaltase from saccharomyces cerevisiae with erythritol. The drug-like activity of erythritol was also assessed.Thereafter, we investigated the effect of erythritol on blood glucose and antioxidant status of normal and streptozocin- nicotinamide-induced diabetes rats which were grouped into five (n = 5); Normal, Ery (normal and administered erythritol), Db (diabetic control), Db + Ery (diabetic and administered erythritol), and Db + Met (diabetic and administered metformin).
Results
Erythritol showed a considerable radical scavenging activity and an ability to inhibit alpha-amylase and alpha-glucosidase in vitro. Also, a significant reduction in glucose intolerance, blood glucose and hemoglobin A1c levels and improved antioxidant level was seen in erythritol-treated diabetic rats.
Conclusion
Erythritol showed anti-oxidant activity, alpha amylase and glucosidase enzyme inhibition property, improved antioxidant status and ameliorated blood glucose, HbA1c, and glucose intolerance following diabetes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reproduction and Bionformatics Research Unit, Ladoke Akintola University of Technology, Ogbomosho, Oyo Nigeria.
- Department of Physiology, Ladoke Akintola University of Technology, Ogbomosho, Oyo Nigeria.
- Department of Physiology, Faculty of Basic Medical Sciences, Thomas Adewumi University, Oko, Kwara State Nigeria.
Zitieren
APA
Soetan, O. A., Ajao, F. O., & Ajayi, A. F. (2023). Blood glucose lowering and anti-oxidant potential of erythritol: An in vitro and in vivo study. Journal of Diabetes & Metabolic Disorders, 22(2), 1217-1229. https://doi.org/10.1007/s40200-023-01237-x
Vancouver
Soetan OA, Ajao FO, Ajayi AF. Blood glucose lowering and anti-oxidant potential of erythritol: An in vitro and in vivo study. Journal of Diabetes & Metabolic Disorders. 2023;22(2):1217-1229. doi:10.1007/s40200-023-01237-x
BibTeX
@article{Soetan2023,
author = {Soetan, O A and Ajao, F O and Ajayi, A F},
title = {Blood glucose lowering and anti-oxidant potential of erythritol: An in vitro and in vivo study},
journal = {Journal of Diabetes & Metabolic Disorders},
year = {2023},
volume = {22},
number = {2},
pages = {1217--1229},
doi = {10.1007/s40200-023-01237-x}
}
EUVIMED